[ad_1]
In his speech to the Italian Senate, the Italian Minister of Health Speranza announced the gospel of vaccination, stating: “The reception of the vaccine is centralized and will be administered free of charge to all Italians without any inequality”. Declaring that the first dose of vaccines should start in January, Minister Speranza stressed that priority will be given to health workers, the elderly and social services. Speranza said Italy has 202 million doses of vaccination options and the resource is sufficient to vaccinate the entire Italian population. Minister Speranza said the country will receive 40.38 million doses of AstraZeneca vaccine, 26 million doses of Pfizer-BioNTech vaccine, 10.769 million doses of Moderna vaccine, 40.38 million doses of Sanofi vaccine, 30.285 million doses of Curevac vaccine and 26.92 million doses of Johnson & Johnson vaccine.
“IF WE TAKE MEASURES, THE 3RD WAVE WAITS BEYOND THE GATE”
class = “cf”>
Explaining that the army will support the distribution of vaccines, Health Minister Speranza said the government has no plans to make the vaccine mandatory. Stating that the case curve has started to decline in the outbreak, Speranza said: “The restraining measures we have put in place with the risk zones model to prevent a general shutdown are paying off.
BELGIUM HAS PLANNED TO BEGIN VACCINATION IN JANUARY
Prime Minister Alexander De Croo said vaccination strategies will become clear within a few days and said: “We have no time to waste. We will be ready on January 5, like many countries.” She said.
Stating that they expect the European Medicines Agency (EMA), the EU medicines regulatory agency, to approve the developed vaccines, De Croo said he wants to vaccinate as many people as possible as soon as the vaccines are ready.
De Croo said it will take some time for everyone to be vaccinated in the country with a population of 11 million and they will start a vaccination campaign with some groups. These groups include health care workers, the elderly and people with chronic diseases.
EMA is currently working with the American pharmaceutical company Pfizer and the Turkish scientist Prof. Dr. The German biotech company BioNTech, of which Uğur Şahin is the founding partner, and the American company Moderna are evaluating the conditional approval requests to the market presented yesterday for developed vaccines. Approvals are scheduled for late December and early January.
.
[ad_2]
Source link
